Related Experiment Video
Updated: May 5, 2026

11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
13.8K
A Novel Valveless Pulsatile Flow Pump for Extracorporeal Blood Circulation.
Joaquín Anatol1, Emanuele Vignali2, Emanuele Gasparotti2
1Departamento de Ingeniería Energética y Fluidomecánica, Universidad de Valladolid, Paseo del Cauce 59, 47011, Valladolid, Spain. joaquin.anatol@uva.es.
Annals of Biomedical Engineering
|January 26, 2025
Summary
A novel valveless Liebau pump offers potential for Extracorporeal Membrane Oxygenation (ECMO) circuits. This pump generates pulsatile flow, a key advantage over existing systems for cardiopulmonary support.
Area of Science:
- Biomedical Engineering
- Cardiovascular Technology
Background:
- Extracorporeal Membrane Oxygenation (ECMO) provides life support for cardiopulmonary failure.
- Current ECMO systems utilize roller or centrifugal pumps.
- These pumps have limitations in biomedical applications.
Purpose of the Study:
- To introduce and evaluate a valveless Liebau pump as a potential replacement for conventional pumps in ECMO circuits.
- To assess the performance of the Liebau pump in a mock circulatory loop and a veno-venous ECMO setup.
Main Methods:
- Construction of a mock circulatory loop simulating right heart hemodynamics.
- Integration of a Liebau pump into a veno-venous ECMO circuit.
- Performance analysis of the Liebau pump under simulated physiological conditions.
Main Results:
- The Liebau pump demonstrated effective flow assistance suitable for pediatric ECMO and low adult blood flow ranges.
- Experimental tests confirmed the pump's ability to generate pulsatile flow.
- Identified advantages of pulsatile flow generation for biomedical applications.
Conclusions:
- The valveless Liebau pump shows promise as an alternative pumping technology for ECMO.
- Its pulsatile flow capability presents significant advantages over existing ECMO pumps.
- Further research may validate its clinical utility in extracorporeal life support.
More Related Videos
Related Concept Videos
Blood Flow
57.5K
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
57.5K
Autoregulation of Blood Flow
10.1K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
10.1K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
385
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
385

